Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
When compared to earlier treatments like blood thinners or surgery, the use of a tiny tool to remove life-threatening blood clots from arteries to the lungs led to a high patient survival rate.
Read Full NewsFindings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.
1.
Mobile prostate cancer screening clinic can ID the disease in disadvantaged men
2.
Clinical trial is testing whether heavy lifting could combat cancer side effects
3.
NIH research cuts leave cancer patient facing hard choice
4.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
5.
A video animation guide to assist young people who are fatigued from cancer.
1.
Hematology Drug Preparation Safety: Ensuring Efficacy and Reducing Risks in Clinical Practice
2.
The Latest Advances in Glioblastoma Treatment and Prevention
3.
AI-Assisted Real-Time Tumor Mapping During Surgery: Transforming Intraoperative Oncology
4.
Optimizing Platelet Transfusions: Balancing Benefits and Risks in Modern Hematology
5.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge